Opko Health Stock Performance
| OPK Stock | USD 1.51 0.01 0.67% |
The company holds a Beta of -0.94, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Opko Health are expected to decrease slowly. On the other hand, during market turmoil, Opko Health is expected to outperform it slightly. Opko Health right now holds a risk of 1.94%. Please check Opko Health semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Opko Health will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Opko Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Opko Health is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
1 | Heres What Key Metrics Tell Us About OPKO Health Q3 Earnings | 11/08/2024 |
2 | Acquisition by Phillip Frost of 14800 shares of Opko Health at 1.78 subject to Rule 16b-3 | 11/12/2024 |
3 | Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.59 subject to Rule 16b-3 | 11/22/2024 |
4 | Acquisition by Phillip Frost of 199072 shares of Opko Health at 1.534 subject to Rule 16b-3 | 11/29/2024 |
5 | OPKO Health, Inc. Stock Position Lowered by Whitefort Capital Management LP | 12/06/2024 |
6 | Acquisition by Phillip Frost of 500000 shares of Opko Health at 1.5621 subject to Rule 16b-3 | 12/11/2024 |
7 | Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.595 subject to Rule 16b-3 | 12/13/2024 |
8 | How IBD Stock Of The Day GeneDx Landed On The IBD 50 And Notched A 2,500 percent Gain | 12/30/2024 |
9 | OPKO Healths ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck | 01/07/2025 |
10 | Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.6198 subject to Rule 16b-3 | 01/10/2025 |
11 | OPKO Health, Inc.s Share Price Could Signal Some Risk | 01/14/2025 |
12 | Acquisition by Phillip Frost of 500000 shares of Opko Health at 1.4817 subject to Rule 16b-3 | 01/15/2025 |
13 | Acquisition by Phillip Frost of 150000 shares of Opko Health at 1.4695 subject to Rule 16b-3 | 01/17/2025 |
14 | Acquisition by Phillip Frost of 47537 shares of Opko Health at 1.4738 subject to Rule 16b-3 | 01/28/2025 |
| Begin Period Cash Flow | 153.2 M |
Opko |
Opko Health Relative Risk vs. Return Landscape
If you would invest 151.00 in Opko Health on November 1, 2024 and sell it today you would earn a total of 0.00 from holding Opko Health or generate 0.0% return on investment over 90 days. Opko Health is generating 0.0185% of daily returns assuming volatility of 1.9441% on return distribution over 90 days investment horizon. In other words, 17% of stocks are less volatile than Opko, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Opko Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opko Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Opko Health, and traders can use it to determine the average amount a Opko Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0095
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OPK |
Estimated Market Risk
| 1.94 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Opko Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Opko Health by adding Opko Health to a well-diversified portfolio.
Opko Health Fundamentals Growth
Opko Stock prices reflect investors' perceptions of the future prospects and financial health of Opko Health, and Opko Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Opko Stock performance.
| Return On Equity | -0.0939 | ||||
| Return On Asset | -0.0897 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.62) % | ||||
| Current Valuation | 1.12 B | ||||
| Shares Outstanding | 672.8 M | ||||
| Price To Earning | 7.46 X | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 1.42 X | ||||
| Revenue | 863.5 M | ||||
| Gross Profit | 84.38 M | ||||
| EBITDA | (65.52 M) | ||||
| Net Income | (188.86 M) | ||||
| Cash And Equivalents | 210.46 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 326.56 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 2.06 X | ||||
| Cash Flow From Operations | (28.2 M) | ||||
| Earnings Per Share | (0.19) X | ||||
| Market Capitalization | 1.01 B | ||||
| Total Asset | 2.01 B | ||||
| Retained Earnings | (2.01 B) | ||||
| Working Capital | 109.42 M | ||||
| Current Asset | 454.06 M | ||||
| Current Liabilities | 251.9 M | ||||
About Opko Health Performance
By examining Opko Health's fundamental ratios, stakeholders can obtain critical insights into Opko Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Opko Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 50.56 | 48.04 | |
| Return On Tangible Assets | (0.36) | (0.37) | |
| Return On Capital Employed | (0.08) | (0.08) | |
| Return On Assets | (0.08) | (0.09) | |
| Return On Equity | (0.12) | (0.13) |
Things to note about Opko Health performance evaluation
Checking the ongoing alerts about Opko Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Opko Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Opko Health may become a speculative penny stock | |
| The company reported the last year's revenue of 863.5 M. Reported Net Loss for the year was (188.86 M) with profit before taxes, overhead, and interest of 84.38 M. | |
| Opko Health has about 210.46 M in cash with (28.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
| Opko Health has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Phillip Frost of 47537 shares of Opko Health at 1.4738 subject to Rule 16b-3 |
- Analyzing Opko Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Opko Health's stock is overvalued or undervalued compared to its peers.
- Examining Opko Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Opko Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Opko Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Opko Health's stock. These opinions can provide insight into Opko Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.